title: Analysis of volumetric response of pituitary adenomas receiving adjuvant CyberKnife stereotactic radiosurgery with the application of an exponential fitting model.
abstract: Tumor control rates of pituitary adenomas (PAs) receiving adjuvant CyberKnife stereotactic radiosurgery (CK SRS) are high. However, there is currently no uniform way to estimate the time course of the disease. The aim of this study was to analyze the volumetric responses of PAs after CK SRS and investigate the application of an exponential decay model in calculating an accurate time course and estimation of the eventual outcome.A retrospective review of 34 patients with PAs who received adjuvant CK SRS between 2006 and 2013 was performed. Tumor volume was calculated using the planimetric method. The percent change in tumor volume and tumor volume rate of change were compared at median 4-, 10-, 20-, and 36-month intervals. Tumor responses were classified as: progression for >15% volume increase, regression for ≤15% decrease, and stabilization for ±15% of the baseline volume at the time of last follow-up. For each patient, the volumetric change versus time was fitted with an exponential model.The overall tumor control rate was 94.1% in the 36-month (range 18-87 months) follow-up period (mean volume change of -43.3%). Volume regression (mean decrease of -50.5%) was demonstrated in 27 (79%) patients, tumor stabilization (mean change of -3.7%) in 5 (15%) patients, and tumor progression (mean increase of 28.1%) in 2 (6%) patients (P = 0.001). Tumors that eventually regressed or stabilized had a temporary volume increase of 1.07% and 41.5% at 4 months after CK SRS, respectively (P = 0.017). The tumor volume estimated using the exponential fitting equation demonstrated high positive correlation with the actual volume calculated by magnetic resonance imaging (MRI) as tested by Pearson correlation coefficient (0.9).Transient progression of PAs post-CK SRS was seen in 62.5% of the patients receiving CK SRS, and it was not predictive of eventual volume regression or progression. A three-point exponential model is of potential predictive value according to relative distribution. An exponential decay model can be used to calculate the time course of tumors that are ultimately controlled.
authors.affiliation: Department of Neurological Surgery, Tri-Service General Hospital Department of Biochemistry School of Public Health Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
authors.forename: Yi-Lin
authors.initials: YL
authors.lastname: Yu
authors.forename: Yun-Ju
authors.initials: YJ
authors.lastname: Yang
authors.forename: Chin
authors.initials: C
authors.lastname: Lin
authors.forename: Chih-Chuan
authors.initials: CC
authors.lastname: Hsieh
authors.forename: Chiao-Zhu
authors.initials: CZ
authors.lastname: Li
authors.forename: Shao-Wei
authors.initials: SW
authors.lastname: Feng
authors.forename: Chi-Tun
authors.initials: CT
authors.lastname: Tang
authors.forename: Tzu-Tsao
authors.initials: TT
authors.lastname: Chung
authors.forename: Hsin-I
authors.initials: HI
authors.lastname: Ma
authors.forename: Yuan-Hao
authors.initials: YH
authors.lastname: Chen
authors.forename: Da-Tong
authors.initials: DT
authors.lastname: Ju
authors.forename: Dueng-Yuan
authors.initials: DY
authors.lastname: Hueng
mesh_terms: D000236:Adenoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D018450:Disease Progression; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy; D016634:Radiosurgery; D012189:Retrospective Studies; D016896:Treatment Outcome; D047368:Tumor Burden / Q000528:radiation effects*; D055815:Young Adult